summary
Introduced
03/29/2021
03/29/2021
In Committee
02/17/2022
02/17/2022
Crossed Over
Passed
Dead
12/31/2022
12/31/2022
Introduced Session
192nd General Court
Bill Summary
For legislation relative to the care and treatment of patients with mitochondrial disease. Financial Services.
AI Summary
This bill requires that health insurance plans provided by the Commonwealth of Massachusetts, as well as individual and group health plans more broadly, must cover treatment for mitochondrial disease. The covered treatments include the use of various vitamin and nutritional supplements such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1, and L-Carnitine. This legislation aims to ensure that patients with mitochondrial disease have access to the necessary treatments and nutritional supplements through their health insurance plans.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (1)
Last Action
Accompanied a study order, see S2917 (on 06/09/2022)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Document Type | Source Location |
---|---|
State Bill Page | https://malegislature.gov/Bills/192/S689 |
Bill | https://malegislature.gov/Bills/192/S689.pdf |
Loading...